FDA Asked To Probe Musk’s Brain Implant Company

March 26, 2024 Business, Medicine

A U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk’s Neuralink before allowing the brain implant company to test its device in humans.

Reuters reported last month that FDA inspectors found problems with record keeping and quality controls for animal experiments at Neuralink last June, less than a month after the startup said it was cleared to test its brain implants in humans.

In a letter to the FDA on Monday, Democratic U.S. Representative Earl Blumenauer said he was concerned the agency ignored “troubling evidence” of animal testing violations that had been raised dating back to at least 2019.

Read the full article.

A U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk’s Neuralink before allowing the brain implant company to test its device in humans. https://t.co/DA4LXbi2NG https://t.co/DA4LXbi2NG

— Reuters Health (@Reuters_Health) March 26, 2024